Levetiracetam in the preventive treatment of transformed migraine: A prospective, open-label, pilot study

Current Therapeutic Research - Clinical and Experimental

Volumn 66, Issue 3, 2005, Pages 212-221

  Rapoport, Alan M ^a,b   Sheftell, Fred D ^b,c   Tepper, Stewart J ^b,d   Bigal, Marcelo E ^b,e  

^a College of Physicians and Surgeons ^*  (United States)

^b NEW ENGLAND CENTER FOR HEADACHE   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Chronic daily headache; Levetiracetam; Prevention; Preventive treatment; Transformed migraine

Indexed keywords

AMITRIPTYLINE; CANDESARTAN; ETIRACETAM; NADOLOL; NORTRIPTYLINE; PROPRANOLOL; VERAPAMIL;

ADULT; ALGORITHM; ANKLE EDEMA; ANORGASMIA; ANXIETY DISORDER; ARTICLE; ASTHENIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION LOSS; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; MALE; MENTAL INSTABILITY; OPEN STUDY; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SCORING SYSTEM; SIDE EFFECT; SOMNOLENCE; STATISTICAL ANALYSIS; THORAX PAIN; TRANSFORMED MIGRAINE; WEIGHT GAIN;

EID: 27944507252     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.curtheres.2005.06.006     Document Type: Article

References (28)

1. Mathew N.T. Medication misuse headache Cephalalgia 18 Suppl 21 1998 34 36
2. Solomon S., Lipton R.B., and Newman L.C. Evaluation of chronic daily headache - comparison to criteria for chronic tension-type headache Cephalalgia 12 1992 365 368
3. Bigal M.E., Sheftell F.D., and Rapoport A.M. Chronic daily headache in a tertiary care population: Correlation between the International Headache Society diagnostic criteria and proposedrevisions of criteria for chronic daily headache Cephalalgia 22 2002 432 438
4. Silberstein S.D., Lipton R.B., and Sliwinski M. Classification of daily and near-daily headaches: Field trial of revised IHS criteria Neurology 47 1996 871 875
5. Spierings E.L. Treatment and outcome of chronic daily headache Otolaryngol Clin North Am 36 2003 1109 1117
6. Freitag F.G. Divalproex sodium extended-release for the prophylaxis of migraine headache Expert Opin Pharmacother 4 2003 1573 1578
7. Brandes J.L., Saper J.R., and Diamond M. for the MIGR 002 Study Group Topiramate for migraine prevention: A randomized controlled trial JAMA 291 2004 965 973
8. Welch K.M., D'Andrea G., and Tepley N. The concept of migraine as a state of central neuronal hyperexcitability Neurol Clin 8 1990 817 828
9. Goadsby P.J. Migraine, aura, and cortical spreading depression: Why are we still talking about it? Ann Neurol 49 2001 4 6
10. Lance J.W., Lambert G.A., Goadsby P.J., and Duckworth J.W. Brainstem influences on the cephalic circulation: Experimental data from cat and monkey of relevance to the mechanism of migraine Headache 23 1983 258 265
11. Welch K.M., Nagesh V., Aurora S.K., and Gelman N. Periaqueductal gray matter dysfunction in migraine: Cause or the burden of illness? Headache 41 2001 629 637
12. Ben-Menachem E. Levetiracetam: Treatment in epilepsy Expert Opin Pharmacother 4 2003 2079 2088
13. Abstract Drake M.E., Greathouse N.I., Armentbright A.D., and Renner J.B. Levetiracetam for preventive treatment of migraine Cephalalgia 21 2001 373
14. Abstract Krusz J.C. Levetiracetam as prophylaxis for resistant headaches Cephalalgia 21 2001 373
15. Available at: Lipton R.B., and Stewart W.E. Migraine Disability Assessment (MIDAS) Questionnaire Accessed 2002 AstraZeneca Pharmaceuticals LP Wilmington, De April 8, 2005
16. Headache Impact Test (HIT-6), version 1.1 2001 QualityMetric, Inc, and GlaxoSmithKline Group of Companies Research Triangle Park, NC April 8, 2005
17. Mathew N.T. Transformed migraine Cephalalgia 13 Suppl 12 1993 78 83
18. Mathew N.T., Reuveni U., and Perez F. Transformed or evolutive migraine Headache 27 1987 102 106
19. Bigal M.E., Rapoport A.M., and Lipton R.B. Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: A comparison of chronic migraine with episodic migraine Headache 43 2003 336 342
20. Magnusson J.E., Riess C.M., and Becker W.J. Effectiveness of a multidisciplinary treatment program for chronic daily headache Can J Neurol Sci 31 2004 72 79
21. Mathew N.T., and Ali S. Valproate in the treatment of persistent chronic daily headache. An open label study Headache 31 1991 71 74
22. Abstract Edwards K.R., and Dreyer M.D. Botulinum toxin type A (Botox) for chronic daily headache Headache 42 2002 429
23. Abstract Shuaib A., Ahmed F., Muratoglu M., and Kochanski P. Topiramate in migraine prophylaxis: A pilot study Cephalalgia 19 1999 379 380
24. Abstract Smith T.R. Zonisamide improves total headache times and headache index in refractory chronic daily headaches, a retrospective case series Headache 42 2002 434
25. Abstract Lake A.E., Saper J.R., and Spierings E.L. Chronic daily headache prophylaxis with tizanidine: A double-blind multicenter study outcome study Headache 42 2002 430
26. Rapoport A.M., Bigal M.E., and Volcy M. Naratriptan in the preventive treatment of refractory chronic migaine: A review of 27 cases Headache 43 2003 482 489
27. Saper J.R., Lake A.E., and Hamel R.L. Daily opioid therapy in the treatment of refractory headache Neurology 62 2004 1687 1694
28. Silberstein S.D. Divalproex sodium in headache: Literature review and clinical guidelines Headache 36 1996 547 555